TED Talk with Barry Schuler on Genomics 101
Monday, March 19, 2012 at 8:27AM
Elliot Turner in Science and Tech, evolution, gene sequencing, genomics, innovator's dilemma

Genomics today is one of those fields where we can witness the Innovator's Dilemma unfold in realtime.  I am particularly intrigued by genetic sequencing for a number of reasons.  The idea that we are simply complex programs with a coding system that has double the inputs of a binary computer system has major consequences in terms of religion, philosophy, and most visibly, health.  This is heavy stuff for a former philosophy major!  Further, the "anti-evolutionists" have a big problem with this reality, because it willingly confirms and implies we are of the same fiber as every living substance on Earth, have thus evolved from the Great Apes, and are already developing the capacity to manipulate the structure of our internal code.  Can we once again call this "debate" over?

In reality, this is a good, not bad thing!  With the understanding of how our most basic system works, we can officially launch into an entirely new era of medical diagnostics and treatment.  While medical costs have been soaring in the United States to the tune of a decade and a half of double-digit growth, genomics, once wildly expensive, holds the key to generating enormous cost and treatment efficiencies.  With knowledge of an individual's genome, we can came up with better treatments for each individual, skip many of the painfully unnecessary diagnostics, and develop a personalized course of action, all at a lower total cost.  

Plus, as an added bonus, we can refine our Pinot Noir grapes to taste as we want it, grow where we want it, how we want it.  I'll let Barry Schuler take over from here on what genomics is doing for us today, and what we can expect to see tomorrow (here's the link in case the embed doesn't work):

Article originally appeared on Compounding My Interests by Elliot Turner (http://compoundingmyinterests.squarespace.com/).
See website for complete article licensing information.